Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Associations of event-related brain potentials and Alzheimer's disease severity: A longitudinal study.

Fruehwirt W, Dorffner G, Roberts S, Gerstgrasser M, Grossegger D, Schmidt R, Dal-Bianco P, Ransmayr G, Garn H, Waser M, Benke T.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 22;92:31-38. doi: 10.1016/j.pnpbp.2018.12.013. [Epub ahead of print]

2.

Usefulness of event-related potentials in the assessment of mild cognitive impairment.

Papaliagkas V, Kimiskidis V, Tsolaki M, Anogianakis G.

BMC Neurosci. 2008 Nov 5;9:107. doi: 10.1186/1471-2202-9-107.

4.

Decreased amplitude of auditory event-related delta responses in Alzheimer's disease.

Caravaglios G, Costanzo E, Palermo F, Muscoso EG.

Int J Psychophysiol. 2008 Oct;70(1):23-32. doi: 10.1016/j.ijpsycho.2008.04.004. Epub 2008 May 27.

PMID:
18502529
5.

Latency variability of the components of auditory event-related potentials to infrequent stimuli in aging, Alzheimer-type dementia, and depression.

Patterson JV, Michalewski HJ, Starr A.

Electroencephalogr Clin Neurophysiol. 1988 Nov-Dec;71(6):450-60.

6.
7.

Influence of education level on design-induced N170 and P300 components of event related potentials in the human brain.

Begum T, Reza F, Ahmed I, Abdullah JM.

J Integr Neurosci. 2014 Mar;13(1):71-88. doi: 10.1142/S0219635214500058. Epub 2014 Mar 13.

PMID:
24738540
8.

[Sex differences in brain stem auditory evoked potentials and P300 examination in patients with mild cognitive impairment and Alzheimer's disease].

Chen W, Wang JQ, Zhang LJ.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 Mar;34(2):172-6. Chinese.

PMID:
15812894
9.

Abnormalities in event-related potential and brainstem auditory evoked response in children with nocturnal enuresis.

Iscan A, Ozkul Y, Unal D, Soran M, Kati M, Bozlar S, Karazeybek AH.

Brain Dev. 2002 Oct;24(7):681-7.

PMID:
12427514
10.

[Evoked potentials N200/P300 disorders and clinical phenotype in Cuban families with paranoid schizophrenia: a family-based association study].

Guerra López S, Martín Reyes M, Pedroso Rodríguez Mde L, Reyes Berazain A, Mendoza Quiñones R, Bravo Collazo TM, Días de Villarvilla T, Machado Cano MJ, Bobés León MA.

Medwave. 2015 Apr 1;15(3):e6112. doi: 10.5867/medwave.2015.03.6112. Spanish.

PMID:
25919584
11.

The role of event-related potentials in cognitive decline in Alzheimer's disease.

Lai CL, Lin RT, Liou LM, Liu CK.

Clin Neurophysiol. 2010 Feb;121(2):194-9. doi: 10.1016/j.clinph.2009.11.001. Epub 2009 Dec 11.

PMID:
20005164
12.

Neuropsychological correlates of the P300 in patients with Alzheimer's disease.

Lee MS, Lee SH, Moon EO, Moon YJ, Kim S, Kim SH, Jung IK.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:62-9. doi: 10.1016/j.pnpbp.2012.08.009. Epub 2012 Aug 23.

PMID:
22940475
13.

Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitude.

Urretavizcaya M, Moreno I, Benlloch L, Cardoner N, Serrallonga J, Menchón JM, Vallejo J.

J Affect Disord. 2003 May;74(3):293-7.

PMID:
12738049
14.

Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer's Disease.

Babić Leko M, Krbot Skorić M, Klepac N, Borovečki F, Langer Horvat L, Vogrinc Ž, Sonicki Z, Hof PR, Šimić G.

Curr Alzheimer Res. 2018;15(13):1244-1260. doi: 10.2174/1567205015666180911151116.

PMID:
30207231
15.

The P300 component in patients with Alzheimer's disease and their biological children.

Ally BA, Jones GE, Cole JA, Budson AE.

Biol Psychol. 2006 May;72(2):180-7. Epub 2005 Dec 5.

PMID:
16337071
16.

P300 energy loss in aging and Alzheimer's disease.

Ashford JW, Coburn KL, Rose TL, Bayley PJ.

J Alzheimers Dis. 2011;26 Suppl 3:229-38. doi: 10.3233/JAD-2011-0061.

PMID:
21971463
17.

Quantitative EEG markers relate to Alzheimer's disease severity in the Prospective Dementia Registry Austria (PRODEM).

Garn H, Waser M, Deistler M, Benke T, Dal-Bianco P, Ransmayr G, Schmidt H, Sanin G, Santer P, Caravias G, Seiler S, Grossegger D, Fruehwirt W, Schmidt R.

Clin Neurophysiol. 2015 Mar;126(3):505-13. doi: 10.1016/j.clinph.2014.07.005. Epub 2014 Jul 12.

PMID:
25091343
18.

[ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].

Asato N, Hirayasu Y, Hiramatsu K, Ohta H.

Seishin Shinkeigaku Zasshi. 1999;101(3):254-76. Japanese.

PMID:
10375977
19.

P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.

Szelies B, Mielke R, Grond M, Heiss WD.

J Neurol Sci. 1995 May;130(1):77-81.

PMID:
7650534
20.

Cognitive MMN and P300 in mild cognitive impairment and Alzheimer's disease: A high density EEG-3D vector field tomography approach.

Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris IY, Hadjileontiadis LJ.

Brain Res. 2016 Oct 1;1648(Pt A):425-433. doi: 10.1016/j.brainres.2016.07.043. Epub 2016 Jul 30.

PMID:
27485659

Supplemental Content

Support Center